Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
-40.4%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.03 | +0.0% |
| 2024 | 0.03 | +101.1% |
| 2023 | -2.84 | -2009.3% |
| 2022 | 0.15 | +86.9% |
| 2021 | 0.08 | - |